A patent request from the pharmaceutical company Gilead for its antiretroviral drug tenofovir was rejected by Brazil Wednesday, Reuters reports. After announcing the decision, a
Source: http://www.medicalnewstoday.com/sections/pharma_industry/
Pharma Industry / Biotech Industry News From Medical News Today